Treace Medical Concepts Inc (TMCI)
5.75
+0.31
(+5.70%)
USD |
NASDAQ |
Nov 05, 16:00
6.70
+0.95
(+16.52%)
After-Hours: 20:00
Treace Medical Concepts Cash from Financing (Quarterly): 0.311M for June 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.311M |
| March 31, 2024 | -0.185M |
| December 31, 2023 | 0.165M |
| September 30, 2023 | 0.159M |
| June 30, 2023 | 1.18M |
| March 31, 2023 | 107.88M |
| December 31, 2022 | 0.297M |
| September 30, 2022 | 0.353M |
| June 30, 2022 | 18.78M |
| Date | Value |
|---|---|
| March 31, 2022 | 1.372M |
| December 31, 2021 | 1.026M |
| September 30, 2021 | 0.041M |
| June 30, 2021 | 107.80M |
| March 31, 2021 | -1.219M |
| December 31, 2020 | 0.323M |
| September 30, 2020 | 9.351M |
| June 30, 2020 | 1.796M |
| March 31, 2020 | 0.033M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-1.219M
Minimum
Mar 2021
107.88M
Maximum
Mar 2023
13.86M
Average
0.338M
Median
Cash from Financing (Quarterly) Benchmarks
| Stryker Corp | 2.653B |
| Perspective Therapeutics Inc | 122.08M |
| Retractable Technologies Inc | -0.1329M |
| Xtant Medical Holdings Inc | 6.434M |
| Catheter Precision Inc | 0.267M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -13.90M |
| Cash from Investing (Quarterly) | 22.43M |
| Free Cash Flow | -41.50M |
| Free Cash Flow Per Share (Quarterly) | -0.2517 |
| Free Cash Flow to Equity (Quarterly) | -15.70M |
| Free Cash Flow Yield | -11.68% |